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•Art and Science
To the Editor:
I was excited when I saw the title of your
March 2000 Editor's Note: "Sex
Appeal." As I read the editorial, I
agreed—something is missing. I also
agreed with your comments on the
need for research and the application of
theory, creativity, and science in moving
the profession forward. Yes, we need
evidence to justify what we do and to
encourage consumer confidence in our
services.
I liked your reference to Star Trek. As
one who was accused of going where
few therapists have gone before, I know
the hope of a better tomorrow in reha-
bilitation. We cannot allow the rest of
the world to move ahead of us, and the
vision you refer to is there; its potential
is just not being maximized.
But you did not balance your comments
appropriately. Medicine, and I include
physical therapy as a big part of that, is
both an "art" and a "science." You
emphasized the "science" part, and
sometimes in today's evidence-based
environment, we forget that there is
also an "art" to what we do. If we put
too much emphasis on the "science"
part, we run the risk of becoming too
technical in our approach to service
delivery, too "cookbook." A wise person
once said, "The long road between sci-
entific work and the care of a patient is
a road of uncertain interpretations,
many of which are subjective in nature."
The "art" part brings in the intuitive
reasoning and the gut passion, those
intangibles that make that special rela-
tionship between the therapist and the
patient not just an intervention, but an
experience. The "art" part allows the
innovative creativity that you refer to.
The "science" part takes from history
and fact, then opens the doorway for
invention and creative innovation. The
"art" part allows us to take the "science"
part and apply it toward the vision and
the needs of the future. That is why
physical therapy is both an "art" and a
"science." Now that is sexy.
Sam Brown, PT
Somerset Physical Therapy
Somerset, Ky
Constraint-Induced Movement
Therapy
To the Editor:
Blanton and Wolf' presented a case
report of a patient with upper-extremity
hemiparesis due to a stroke who
received constraint-induced movement
therapy. The Wolf Motor Function Test
(WMFT) and the Motor Activity Log
(MAL) were applied to assess the effect
of the treatment. We are concerned
about the use of these outcome mea-
sures, the clinimetric quality of which is
still uncertain. Apparently, the validity
of data obtained with the WMFT and
the MAL has never been evaluated. The
interrater reliability was reported to
range from .95 to .97 for the WMFT
and to be .94 for the quality-of-
movement scale of the MAL. Despite
careful and repeated readings, we were
unable to find the reliability value of. 94
in the reference cited.'
We agree with the suggestion of Blan-
ton and Wolf that "ffluture studies
including large sample sizes within a
randomized clinical trial should be con-
sidered."" P"' In fact, an observer-
blinded randomized clinical trial on the
effectiveness of treatment involving
forced use of the upper extremities in
66 patients has been performed at our
hospital.' In this trial, the MAL was
used as a secondary outcome measure.'
We found 1.2 and 0.7 points mean
improvement on the amount-of-use
scale of the MAL after the intervention
in the experimental and control groups,
respectively (corrected for baseline dif-
ferences and presence or absence of
hemi-neglect). The surprising improve-
ment in the control group might be due
to a placebo effect or a "hello-goodbye
effect." The latter term refers to the
observation that patients may exagger-
ate their problems before therapy, hop-
ing to be eligible for the intervention,
and minimize their problems at the end
of the intervention to "please" the staff
with their improvement.'
In our opinion, the risk of eliciting a
socially desirable answer from the
patient to the MAL questions is
enhanced when the MAL is adminis-
tered daily during the treatment phase,
as Blanton and Wolf described. It
should be noted that the MAL is essen-
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tially a "subjective" measure, meaning
that the patient's ratings may be influ-
enced by his or her expectations as well
as those of the interviewer, which may
be unconsciously expressed in the way
the questions are posed. To assess its
criterion validity, the use of the affected
arm during functional activities should
be observed in the patient's home envi-
ronment, but for many practical rea-
sons this would not be feasible.
Alternatively, by using the instrument
as a secondary outcome measure in a
trial, along with primary outcome mea-
sures with known clinimetric proper-
ties, more insight can be obtained into
its construct and content validity,
reproducibility, and responsiveness.
We used the Action Research Arm Test
and the Rehabilitation Activities Profile
as primary outcome measures in our
trial, both of which have been shown to
yield valid and reliable measure-
ments.'"
Until more is known about the clini-
metric properties of the WMFT and the
MAL, we recommend that these instru-
ments should not be applied as pri-
mary outcome measures in a trial that
is intended to give a valid answer
regarding the effectiveness of an inter-
vention for improving upper-extremity
function.
Johanna H van der Lee, MD
Heleen Beckerman, PT, PhD
GustaafJ Lankhorst, MD, PhD
University Hospital, Vrije Universiteit
Lex M Bouter, PhD
Institute for Research in Extramural
Medicine
Vrzje Universiteit
Amsterdam, the Netherlands
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Author Response:
We thank Dr van der Lee, Dr Becker-
man, Dr Lankhorst, and Dr Bouter for
their interest in our case report' and
for the thought-provoking comments
they have offered. We will respond to
their comments in the order in which
they were presented.
There is clear indication that the Motor
Activity Log (MAL), developed in both
its preliminary form' and its present
form' by Taub and his team at the Uni-
versity of Alabama at Birmingham,
yields reliable measurements when
they are obtained repeatedly before
intervention and over an extended
time interval." According to Uswatte
and Taub,' at least one dimension of
validity is reflected in high correlations
(intraclass	 correlation	 coefficient
[3,1)=.90) between patient and care-
giver scores obtained separately from
one another at different points in time.
With respect to the Wolf Motor Func-
tion Test (WMFT), we do have prelimi-
nary data on the reliability and validity
of WMFT scores, but the data are not
yet published in a peer-reviewed form.
Briefly, our preliminary data show that
intraclass	 correlation	 coefficients
ranged from .97 for raters performing
repeated measures among subjects with
no known cardiovascular impairments
to .99 for the same measures among
age- and sex-matched patients with
stroke. Moreover, there was excellent
concurrent validity with data obtained
with the Fugl-Meyer Upper Extremity
Assessment Test." Although these data
are not as yet published, correlations
were —.54 (P=.0166) at a first rating
session and —.68 (P=.0014) at a second
session measured among 19 patients
with chronic stroke, with sessions sepa-
rated by 14 to 16 days.
There was no difficulty in discriminat-
ing between the WMFT scores of sub-
jects without stroke and those of
subjects who were poststroke. The reli-
ability value of .94 initially ascribed to
the Miltner and colleagues' should
have been referenced to a report by
Taub et al' and to an article by Taub
et al' that indicated no change in a con-
trol group's MAL scores from pretreat-
ment to posttreatment measurements.
Further explanation about the reliabil-
ity of MAL scores is addressed in a let-
ter to the editor by Taub and Uswatte
that appeared recently in Stroke!
We have begun a blinded, crossover,
national randomized clinical trial on
constraint-induced movement therapy
among patients with subacute stroke.
This trial has been given the acronym
EXCITE	 (EXtremity	 Constraint-
Induced Therapy Evaluation). We plan
to recruit at least 240 subjects from 7
locations, and we will use the same pro-
tocol as described in our case report.'
The subject in our case report was part
of the pilot study done in preparation
for this EXCITE trial. Our group is well
aware of the published randomized
trial" to which van der Lee and col-
leagues refer. We suspect that the less
favorable results seen by the van der
Lee group were perhaps due to the fact
that their subjects had higher baseline
MAL scores than did our subjects.
Another variable affecting outcomes
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may be that the intensity of interven-
tion used in their study was not as pro-
found as that used in our work or as
used by Taub and his colleagues. In
fact, the baseline score on the amount-
of-use scale of the MAL reported by
van der Lee et al' (2.2 points)
approaches the exclusion criterion for
our clinical trial; that is, their patients
may be too high functioning for them
to see substantive change.
We do not think that the improvement
in the control group in the study by van
der Lee et al is due primarily to a
placebo effect. Their control patients
were actually receiving a physical
therapy—based treatment, the intensity
of which might easily have fostered
some improvement. We question seri-
ously the possibility that our patient
was attempting to please us in this case
report. In fact, she was even reluctant
to participate. During her exit inter-
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view, there appeared to be no indica-
tion that her effort was directed toward
accommodating to the wishes of the
investigators. Her continued improve-
ment for the next 3 months would tend
to dispel that notion, as any intended
or inadvertent behavioral modification
on our part would most likely have dis-
sipated.
We do not question the subjective
aspects of the MAL. As noted earlier,
the high correlation between caregiver
and subject responses supports the
belief that a high degree of concor-
dance exists beyond subjectivity. The
MAL is not intended to condition
patients into providing "expected"
responses, nor will it be offered repeat-
edly during the clinical trial. It was
administered daily in this case report to
provide us with a running account of
changes in patient perception of real-
world use of the affected limb. At no
time did the patient see scores from
previous days, nor is there any reason
to believe that these previous scores
over 10 days were retained in memory.
Another alternative for assessing crite-
rion validity for limb use in everyday
activities is to monitor adherence to
wearing a constraint for the less
impaired arm, which can be done
through use of a contact switch embed-
ded within a splint and interfaced to a
microprocessor (counter). Additionally,
a proxy, but objective, measure for limb
usage can be secured through monitor-
ing motions using accelerometry.
Uswatte et al' have developed this
approach. Monitoring adherence to
splint use and limb use with accelerom-
etry is an important feature incorpo-
rated into our clinical trial.
There is little doubt that other clinical
measures, such as the Action Research
Arm Test and the Rehabilitation Activi-
ties Profile, could be important out-
come measures. We feel they may not
be most appropriate for subjects with
the motoric characteristics sought in
our work. We hope that the informa-
tion presented in this response sheds
more light on the psychometric prop-
erties of the MAL and the WMFT.
Hopefully, clinicians wanting to use
these tests will recognize that their
value is augmented by their simplicity
and the ease with which these real-
world and laboratory-based measures
can be complemented with more
expensive, objective (ie, reliable)
physiological tools.
Sarah Blanton, PT, MPT
Steven L Wolf PT, PhD, FAPTA
Department of Rehabilitation Medicine
Emory University School of Medicine
Center for Rehabilitation Medicine
Atlanta, GA 30322
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